Research on functional analysis of circulating tumor cells in association with cancer metastasis.
Project/Area Number |
21390181
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Laboratory medicine
|
Research Institution | Kyoto University |
Principal Investigator |
TOI Masakazu 京都大学, 医学研究科, 教授 (10207516)
|
Co-Investigator(Kenkyū-buntansha) |
ISHIGURO Hirosh 京都大学, 医学研究科, 講師 (20422925)
OHNO Shinji 独立行政法人国立病院機構, 九州がんセンター臨床研究部乳腺科 (50203881)
UENO Takayuki 京都大学, 医学研究科, 助教 (40452362)
TSUJI Wakako 京都大学, 医学研究科, 助教 (00531815)
OKABE Hiroshi 京都大学, 医学研究科, 准教授 (10335250)
岩田 広治 愛知がんセンター, 乳腺科, 部長 (90295600)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥19,500,000 (Direct Cost: ¥15,000,000、Indirect Cost: ¥4,500,000)
Fiscal Year 2011: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2010: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2009: ¥8,320,000 (Direct Cost: ¥6,400,000、Indirect Cost: ¥1,920,000)
|
Keywords | 腫瘍検査学 / 血中循環癌細胞 / 転移 / アポトーシス / M30 / EpCAM / P-cadherin / 上皮間葉転換 / CTC / EMT / ZEB1 / 乳癌 / サイトケラチン / 混合抗体 / CD44 / cytokeratin / 胃癌 |
Research Abstract |
We investigated the way to improve sensitivity and reproducibility of CTC assay. Recovery rate of basal type phenotype was improved with additional staining with anti-EpCAM antibody and anti-P-cadherin antibody. CTC count and viability in patients with breast cancer who received neoajuvant chemotherapy was also evaluated. Evaluation of CTC viability using M30 may help to evaluate response of neoadjuvant chemotherapy.
|
Report
(4 results)
Research Products
(10 results)
-
[Journal Article] Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer2010
Author(s)
Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E
-
Journal Title
Breast Cancer
Volume: 17(3)
Issue: 3
Pages: 199-204
DOI
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-